PD-L1 Biomarker- OptraSCAN Inc



OptraSCAN Inc offers
PD-L1 biomarker & immune-oncology biomarker analysis for immune-oncology – programmed death-ligand 1 (PD-l1) expression.

Programmed Cell Death Ligand-1 expression of PD-L1 is a very important cancer biomarker and it has become a critical part of patient management for immunotherapy. The targeted blockade of PD-L1 helps to restore the antitumor response.


Because of the development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors. It has been indicated that PD-L1 expression on both tumor and tumor-associated immune cells is associated with clinical outcomes.

Optrascan’s Solution For Immuno - Oncology:

-         -  It’s an automated image analysis (for research use) which supports the interpretation of PD-L1I HC expression on both tumor and immune cells in solid tumors.

-         -= They determines PD-L1 expression on tumor and immune cells showing partial or complete membrane staining on a tumor cell along with membrane and/or cytoplasmic staining on immune cells in a single read.

-         - It is very reliable and can be used to assess PD- L1 expression in a more objective manner.


Tel: +1-408-524-5300

Contact us at- info@optrascan.com

Read more about- Immuno - Oncology Biomarker Analysis

Comments

Popular posts from this blog

Whole Slide Scanners By OptraSCAN

Digital Pathology Solution- OptraSCAN Inc

Histopathology Slide Scanner- Optrascan Inc